IRBM

Pomezia, Italy Founded: 2010 • Age: 16 yrs
Integrated drug discovery and preclinical development services are provided.
Request Access

About IRBM

IRBM is a company based in Pomezia (Italy) founded in 2010 by Ilaria Di Lorenzo and Piero Di Lorenzo.. IRBM offers products and services including Small Molecule Discovery, Peptide Drug Discovery, and Antibody Discovery. IRBM operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and Bioduro, among others.

  • Headquarter Pomezia, Italy
  • Founders Ilaria Di Lorenzo, Piero Di Lorenzo
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Irbm S.P.A.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $36.79 K (USD), Grant

    Jan 01, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of IRBM

IRBM offers a comprehensive portfolio of products and services, including Small Molecule Discovery, Peptide Drug Discovery, and Antibody Discovery. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Services for identifying and developing small molecule therapeutics

Development of peptide-based drugs for various applications

Platform for discovering and characterizing antibodies

People of IRBM
Headcount 200-500
Employee Profiles 2
Employee Profiles
People
Ali Hoseini
Business Development Director - Europe

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of IRBM

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $36,791
  • First Round

    (01 Jan 2017)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2021 Amount Grant - IRBM Valuation

investors

Jan, 2017 Amount Grant - IRBM Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in IRBM

IRBM has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by IRBM

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - IRBM

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Irbm Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of IRBM

IRBM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and Bioduro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
domain founded_year HQ Location
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
domain founded_year HQ Location
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
domain founded_year HQ Location
Fluorinated compounds are synthesized and manufactured customly for various industries.
domain founded_year HQ Location
Integrated drug discovery and development services
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Irbm

Frequently Asked Questions about IRBM

When was IRBM founded?

IRBM was founded in 2010 and raised its 1st funding round 7 years after it was founded.

Where is IRBM located?

IRBM is headquartered in Pomezia, Italy. It is registered at Pomezia, Lazio, Italy.

What does IRBM do?

IRBM was founded in 2010 and is based in Pomezia, Italy. Services in the pharmaceutical sector are delivered, encompassing target validation, hit identification, lead optimization, in vitro pharmacology, preclinical research, peptide therapeutics, and assay development screening. Integrated solutions for drug discovery and early-stage development are supported through these operations, aiding research in life sciences.

Who are the top competitors of IRBM?

IRBM's top competitors include Sai Life Sciences, Acies Bio and Medicilon.

What products or services does IRBM offer?

IRBM offers Small Molecule Discovery, Peptide Drug Discovery, and Antibody Discovery.

Who are IRBM's investors?

IRBM has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available